Evidence map›Paper›PMID 16047092›Full record

ArticleJournal of genetic counseling2005

Women's attitudes toward testing for fragile X carrier status: a qualitative analysis.

Aimee Anido, Lisa M Carlson, Lisa Taft, Stephanie L Sherman

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of genetic counseling, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 4 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 4 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Article
  6. Article
  7. Article
  8. Informed decision making and psychosocial outcomes in pregnant and nonpregnant women offered population fragile X carrier screening.Genetics in medicine : official journal of the American College of Medical Genetics · 2017
    Article
  9. Harms of Deception in FMR1 Premutation Genotype-Driven Recruitment.The American journal of bioethics : AJOB · 2017
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Newborn screening and cascade testing for FMR1 mutations.American journal of medical genetics. Part A · 2013
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Aimee AnidoDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Lisa M Carlson
Lisa Taft
Stephanie L Sherman
Emory University · US

Funding

Genetics Epidemiology of the FMR1 GeneR01HD029909 · NICHD · EMORY UNIVERSITY · PI SHERMAN, STEPHANIE L. · 1994 to 2009
$6.1M
TRANSCRIPTION AND RNA BINDING IN FRAGILE X SYNDROMEP01HD035576 · NICHD · EMORY UNIVERSITY · PI WARREN, STEPHEN T. · 1997 to 2005
$5.0M
NICHD NIH HHS P01 HD35576NICHD NIH HHS R01 HD29909
6 · The paper itself

Abstract

Fragile X syndrome (FXS) is primarily due to a repeat expansion mutation found in the FMR1 X-linked gene. We have conducted a qualitative analysis of responses from women concerning their attitudes toward testing for carrier status of the fragile X mutation among reproductive-age women. We obtained responses from focus groups including women with and without FXS in their families. We found the following themes: (1) mothers of children with FXS have difficulty formulating their opinions on population screening because of their unique experiences surrounding their own carrier diagnosis and their relationship with their children with FXS, (2) the motivation for carrier testing and need for information differ by family history of FXS and parental status, and (3) the timing of carrier testing with respect to a woman's life stage dictates whether carrier information will be viewed as beneficial or detrimental. There was evidence that non-carrier women from the general population would be wholly unprepared for positive carrier results. These findings have significant implications for genetic counseling as well as for population screening.

Indexed as

AttitudeDNA Mutational AnalysisFemaleFragile X Messenger Ribonucleoprotein 1Fragile X SyndromeGenetic Carrier ScreeningGenetic TestingHumansMotivationPoint MutationFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1Empirical ApproachGenetics and Reproduction

Identifiers

PMID16047092
OpenAlexW2151516081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.